Related Experiment Video
Updated: Mar 31, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver
A D B Vliegenthart1, J M Shaffer2, J I Clarke3
1Pharmacology, Toxicology and Therapeutics, University/BHF Centre for Cardiovascular Science, Edinburgh University, UK.
Abstract:
Our objective was to identify microRNA (miRNA) biomarkers of drug-induced liver and kidney injury by profiling the circulating miRNome in patients with acetaminophen overdose. Plasma miRNAs were quantified in age- and sex-matched overdose patients with (N = 27) and without (N = 27) organ injury (APAP-TOX and APAP-no TOX, respectively). Classifier miRNAs were tested in a separate cohort (N = 81). miRNA specificity was determined in non-acetaminophen liver injury and murine models. Sensitivity was tested by stratification of patients at hospital presentation (N = 67). From 1809 miRNAs, 75 were 3-fold or more increased and 46 were 3-fold or more decreased with APAP-TOX. A 16 miRNA classifier model accurately diagnosed APAP-TOX in the test cohort. In humans, the miRNAs with the largest increase (miR-122-5p, miR-885-5p, miR-151a-3p) and the highest rank in the classifier model (miR-382-5p) accurately reported non-acetaminophen liver injury and were unaffected by kidney injury. miR-122-5p was more sensitive than ALT for reporting liver injury at hospital presentation, especially combined with miR-483-3p. A miRNA panel was associated with human kidney dysfunction. In mice, miR-122-5p, miR-151a-3p and miR-382-5p specifically reported APAP toxicity - being unaffected by drug-induced kidney injury. Profiling of acetaminophen toxicity identified multiple miRNAs that report acute liver injury and potential biomarkers of drug-induced kidney injury.
Insights
New biomarkers for drug-induced liver and kidney injury were identified using microRNA (miRNA) profiling in acetaminophen overdose patients. Specific miRNAs accurately detected liver injury and showed potential for diagnosing kidney dysfunction.
Area of Science:
- Biochemistry
- Genomics
- Toxicology
Background:
- Drug-induced organ injury, particularly liver and kidney damage, poses a significant clinical challenge.
- Acetaminophen overdose is a leading cause of acute liver failure.
- Identifying reliable biomarkers for early detection and monitoring of drug-induced organ injury is crucial.
Purpose of the Study:
- To identify circulating microRNA (miRNA) biomarkers for drug-induced liver and kidney injury.
- To profile the miRNome in patients with acetaminophen overdose and organ injury.
- To develop and validate a miRNA-based diagnostic model for acetaminophen-induced liver toxicity.
Main Methods:
- Plasma miRNAs were quantified in patients with and without acetaminophen-induced organ injury (APAP-TOX).
- A 16-miRNA classifier model was developed and tested in a separate cohort.
- miRNA specificity was assessed in non-acetaminophen liver injury models and murine models; sensitivity was evaluated at hospital presentation.
Main Results:
- A 16-miRNA classifier model accurately diagnosed acetaminophen-induced liver toxicity in a test cohort.
- Specific miRNAs (e.g., miR-122-5p, miR-885-5p, miR-151a-3p, miR-382-5p) accurately reported liver injury, independent of kidney injury.
- A panel of miRNAs was associated with human kidney dysfunction, and certain miRNAs specifically reported acetaminophen toxicity in mice.
Conclusions:
- Circulating miRNAs can serve as effective biomarkers for acute liver injury induced by acetaminophen.
- The identified miRNA panel shows potential for diagnosing drug-induced kidney injury.
- miRNA profiling offers a promising approach for early detection and management of drug-induced organ toxicities.
More Related Videos
10:23Absolute Quantification of Plasma MicroRNA Levels in Cynomolgus Monkeys, Using Quantitative Real-time Reverse Transcription PCR
Published on: February 12, 2018
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022